Tag Archives: anthracyclines

Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors

Posted on July 25, 2010 by wngai

Pancreatic neuroendocrine tumors affect the hormone-producing tissues within the pancreas, and have an incidence rate, affecting only 2 to 4 people per million worldwide.   The incidence, however, is rising, and has quadrupled in the past 30 years, according to data … Continue reading →

Posted in Cancer, Pancreatic Cancer | Tagged , , , , , , , , , , , , | Comments Off on Everolimus (Affinitor) Improves Survival in Pancreatic Neuroendocrine Tumors

New Hope for Heavily Pretreated Metastatic Breast Cancer Patients

Posted on June 26, 2010 by wngai

A new chemotherapy agent, eribulin (developed by Eisai), was shown to improve significant survival benefit in heavily pretreated breast cancer, according to the EMBRACE study presented at the American Society of Clinical Oncology (ASCO) 2010 Annual Meeting. The new drug … Continue reading →

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , | Comments Off on New Hope for Heavily Pretreated Metastatic Breast Cancer Patients

Best Regimen Sequence for Early Breast Cancer patients

Posted on March 7, 2010 by wngai

Which is the best chemotherapy adjuvant regimen sequence for early breast cancer? It is widely known that anthracyclines (epirubicin and doxorubicin) and taxanes is the best adjuvant chemotherapy regimen for early breast cancer. However, should anthracyclines be always administered before taxanes? An article published … Continue reading →

Posted in Breast cancer, Cancer | Tagged , , , , , , , | Comments Off on Best Regimen Sequence for Early Breast Cancer patients